DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Markets and Manufacturing Technologies for Protein Drugs" report to their offering.
The global protein drugs market reached nearly $174.7 billion in 2015 and should reach nearly $248.7 billion by 2020 at a compound annual growth rate (CAGR) of 7.3% through 2020.
This report will provide:
- An overview of the markets for each major class of protein in the segments therapeutic monoclonal antibodies, cytokines, peptide hormones, vaccines, and blood products
- Discussion covering the strength and weaknesses of each type of technology in light of the new technologies, growing competition, and changing customer needs
- Examinations of current successes, including the size and sales forecast for each class in the next five years
- Evaluation of challenges such as delivery methods and side effects
- Consideration of issues regarding add-on products and patent protection
The scope of this study covers manufacturing of protein drugs technologies. Each market and its applications, regulatory environment, technology, market projections and market shares were analyzed. Technological issues include the latest trends and developments. This report covers the currently used six techniques in manufacturing of protein therapeutics, which includes fractionation from natural human/animal sources, microbial fermentation, cell culture, chemical synthesis, transgenics and embryonated eggs.
Companies Mentioned Include:
- Abbvie Inc.
- Actavis Inc.
- Alexion Pharmaceuticals
- Allergan PLC
- Apotex Inc.
- Baxalta Inc
- Bayer Pharma AG
- Biogen Inc.
- Biomarin Pharmaceutical Inc
- Fresenius Kabi USA
- Glaxosmithkline
- Grifols USA LLC
- Hospira Inc
- Johnson & Johnson
- Octapharma AG
- Pfizer Inc
- Protein Sciences Corp.
- Revo Biologics Inc.
- Sandoz
- Sanofi Inc
- Seattle Genetics Inc.
- UCB Company
- Shire PLC (Viropharm Inc.)
-
Vertex Pharmaceuticals
Report Structure:
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Overview
Chapter 4: Regulatory Aspects
Chapter 5: New Developments
Chapter 6: Market Analysis By Type
Chapter 7: Market Analysis By Manufacturing Process
Chapter 8: Industry Structure
Chapter 9: Patent Analysis
Chapter 10: Current Situation
Chapter 11: Company Profiles
Chapter- 12: Appendix I - Abbreviations
For more information visit http://www.researchandmarkets.com/research/5pxbms/global_markets
